Keywords: intermune, completes, ph, iii, ipf, trial, enrollment

InterMune completes Ph III IPF trial enrollment

Article | 23 August 2001

Print This

InterMune has completed enrollment in a Phase III clinical trial toevaluate the safety and efficacy of its Actimmune (interferon gamma-1 ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in